Minimal change disease and acute interstitial nephritis following SARS-CoV-2 BNT162b2 vaccination

Pediatr Nephrol. 2022 Jun;37(6):1419-1421. doi: 10.1007/s00467-022-05470-z. Epub 2022 Feb 7.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Comment

MeSH terms

  • BNT162 Vaccine* / adverse effects
  • COVID-19* / prevention & control
  • Humans
  • Nephritis, Interstitial* / chemically induced
  • Nephrosis, Lipoid* / chemically induced
  • SARS-CoV-2
  • Vaccination / adverse effects

Substances

  • BNT162 Vaccine

Supplementary concepts

  • Acute Tubulointerstitial Nephritis